An interleukin-1 beta-encoding retrovirus exhibits enhanced replication in vivo

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 155-164

  Browne, Edward P ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD69 ANTIGEN; DOUBLE STRANDED DNA; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DENDRITIC CELL; DNA SEQUENCE; GLYCOSYLATION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PLASMID; PROTEIN SECRETION; RETROVIRUS INFECTION; SPLENOMEGALY; STOP CODON; VIRUS ACTIVATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; EXPERIMENTAL LEUKEMIA; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRULENCE; VIRUS INFECTION;

MURINE LEUKEMIA VIRUS; MUS;

ANIMALS; HOST-PATHOGEN INTERACTIONS; INTERLEUKIN-1BETA; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT PROTEINS; RETROVIRIDAE INFECTIONS; SPLENOMEGALY; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRULENCE; VIRUS REPLICATION;

EID: 84919460198     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02314-14     Document Type: Article

References (55)

1. Walker BD, Burton DR. 2008. Toward an AIDS vaccine. Science 320: 760-764. http://dx.doi.org/10.1126/science.1152622.
2. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, Self SG, Borrow P. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83:3719-3733. http://dx.doi.org/10.1128/JVI.01844-08.
3. Medzhitov R, Littman D. 2008. HIV immunology needs a new direction. Nature 455:591. http://dx.doi.org/10.1038/455591a.
4. Browne EP. 2011. Toll-like receptor 7 controls the anti-retroviral germinal center response. PLoS Pathog 7:e1002293. http://dx.doi.org/10.1371/journal.ppat.1002293.
5. Kane M, Case LK, Wang C, Yurkovetskiy L, Dikiy S, Golovkina TV. 2011. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity 35:135-145. http://dx.doi.org/10.1016/j.immuni.2011.05.011.
6. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M. 2009. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955-959. http://dx.doi.org/10.1038/nm.2004.
7. Rua R, Lepelley A, Gessain A, Schwartz O. 2012. Innate sensing of foamy viruses by human hematopoietic cells. J Virol 86:909-918. http://dx.doi.org/10.1128/JVI.06235-11.
8. Browne EP. 2013. Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses. J Virol 87:7357-7366. http://dx.doi.org/10.1128/JVI.00788-13.
9. Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, Altfeld M. 2007. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol 178:7658-7666. http://dx.doi.org/10.4049/jimmunol.178.12.7658.
10. Beignon A-S, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115:3265-3275. http://dx.doi.org/10.1172/JCI26032.
11. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR. 2010. Acryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467:214-217. http://dx.doi.org/10.1038/nature09337.
12. Oh D-Y, Baumann K, Hamouda O, Eckert JK, Neumann K, Kücherer C, Bartmeyer B, Poggensee G, Oh N, Pruss A, Jessen H, Schumann RR. 2009. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 23:297-307. http://dx.doi.org/10.1097/QAD.0b013e32831fb540.
13. Said EA, Al-Yafei F, Zadjali F, Hasson SS, Al-Balushi MS, Al-Mahruqi S, Koh CY, Al-Naamani K, Al-Busaidi JZ, Idris MA, Balkhair A, Al-Jabri AA. 2014. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection. Immunol Lett 160:58-64. http://dx.doi.org/10.1016/j.imlet.2014.04.005.
14. Monroe KM, Yang Z, Johnson JR, Geng X, Doitsh G, Krogan NJ, Greene WC. 2014. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343:428-432. http://dx.doi.org/10.1126/science.1243640.
15. Doitsh G, Galloway NLK, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Muñoz-Arias I, Greene WC. 2014. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505:509-514. http://dx.doi.org/10.1038/nature12940.
16. Garlanda C, Dinarello CA, Mantovani A. 2013. The interleukin-1 family: back to the future. Immunity 39:1003-1018. http://dx.doi.org/10.1016/j.immuni.2013.11.010.
17. Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E. 2006. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25:387-408. http://dx.doi.org/10.1007/s10555-006-9004-4.
18. Lachmann HJ, Quartier P, So A, Hawkins PN. 2011. The emerging role of interleukin-1β in autoinflammatory diseases. Arthritis Rheum 63:314-324. http://dx.doi.org/10.1002/art.30105.
19. Ipp H, Zemlin AE, Erasmus RT, Glashoff RH. 2014. Role of inflammation in HIV-1 disease progression and prognosis. Crit Rev Clin Lab Sci 51:98-111. http://dx.doi.org/10.3109/10408363.2013.865702.
20. Cheung SC, Chattopadhyay SK, Morse HC, Pitha PM. 1991. Expression of defective virus and cytokine genes in murine AIDS. J Virol 65:823-828.
21. Allcock RJ, Peacock CD, Price P. 1996. The inflammatory macrophage response to MCMV in mice with a retroviral immunodeficiency syndrome (MAIDS). J Leukoc Biol 60:44-50.
22. Robertson MN, Miyazawa M, Mori S, Caughey B, Evans LH, Hayes SF, Chesebro B. 1991. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods 34:255-271. http://dx.doi.org/10.1016/0166-0934(91)90105-9.
23. Chesebro B, Wehrly K, Cloyd M, Britt W, Portis J, Collins J, Nishio J. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friendspecific and FMR-specific antigens. Virology 112:131-144. http://dx.doi.org/10.1016/0042-6822(81)90619-X.
24. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
25. Portis JL, McAtee FJ, Kayman SC. 1992. Infectivity of retroviral DNA in vivo. J Acquir Immune Defic Syndr 5:1272-1273. http://dx.doi.org/10.1097/00126334-199212000-00011.
26. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DAA. 2004. Correction of multi-gene deficiency in vivo using a single "self-cleaving" 2A peptide-based retroviral vector. Nat Biotechnol 22:589-594. http://dx.doi.org/10.1038/nbt957.
27. + T-cell-mediated pathogen control. J Virol 81:11881-11890. http://dx.doi.org/10.1128/JVI.01554-07.
28. Elkabets M, Ribeiro VSG, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, Vosshenrich CAJ. 2010. IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol 40:3347-3357. http://dx.doi.org/10.1002/eji.201041037.
29. Vollbrecht T, Stirner R, Tufman A, Roider J, Huber RM, Bogner JR, Lechner A, Bourquin C, Draenert R. 2012. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26:F31-37. http://dx.doi.org/10.1097/QAD.0b013e328354b43f.
30. Qin A, Cai W, Pan T, Wu K, Yang Q, Wang N, Liu Y, Yan D, Hu F, Guo P, Chen X, Chen L, Zhang H, Tang X, Zhou J. 2013. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J Virol 87:1477-1490. http://dx.doi.org/10.1128/JVI.01759-12.
31. Hazenberg MD, Otto SA, van Benthem BHB, Roos MTL, Coutinho RA, Lange JMA, Hamann D, Prins M, Miedema F. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17:1881-1888. http://dx.doi.org/10.1097/00002030-200309050-00006.
32. Hasenkrug KJ, Dittmer U. 2007. Immune control and prevention of chronic Friend retrovirus infection. Front Biosci 12:1544-1551. http://dx.doi.org/10.2741/2167.
33. Hasenkrug KJ, Chesebro B. 1997. Immunity to retroviral infection: the Friend virus model. Proc Natl Acad Sci USA 94:7811-7816. http://dx.doi.org/10.1073/pnas.94.15.7811.
34. Persons DA, Paulson RF, Loyd MR, Herley MT, Bodner SM, Bernstein A, Correll PH, Ney PA. 1999. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat Genet 23:159-165. http://dx.doi.org/10.1038/13787.
35. Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, Chesebro B, Hasenkrug KJ, Greene WC. 2008. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321:1343-1346. http://dx.doi.org/10.1126/science.1161121.
36. MacDonald ME, Mak TW, Bernstein A. 1980. Erythroleukemia induction by replication-competent typeCviruses cloned from the anemia-and polycythemia-inducing isolates of Friend leukemia virus. J Exp Med 151: 1493-1503. http://dx.doi.org/10.1084/jem.151.6.1493.
37. Niho Y, Shibuya T, Mak TW. 1982. Modulation of erythropoiesis by the helper-independent Friend leukemia virus F-MuLV. J Exp Med 156:146-158. http://dx.doi.org/10.1084/jem.156.1.146.
38. Mukhopadhyaya R, Richardson J, Nazarov V, Corbin A, Koller R, Sitbon M, Wolff L. 1994. Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions. J Virol 68:5100-5107.
39. + T cells leads to reversible immune dysfunction. Nat Med 12:1198-1202. http://dx.doi.org/10.1038/nm1482.
40. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354. http://dx.doi.org/10.1038/nature05115.
41. Jespersen T, Duch M, Carrasco ML, Warming S, Pedersen FS. 1999. Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. Gene 239:227-235. http://dx.doi.org/10.1016/S0378-1119(99)00402-3.
42. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, Hendrickson SB, Guo HG, Hayward GS, Reitz MS. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3:287-292. http://dx.doi.org/10.1038/nm0397-287.
43. Chang WLW, Baumgarth N, Yu D, Barry PA. 2004. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 78:8720-8731. http://dx.doi.org/10.1128/JVI.78.16.8720-8731.2004.
44. Datta SK, Melief CJ, Schwartz RS. 1975. Lymphocytes and leukemia viruses: tropism and transtropism of murine leukemia virus. J Natl Cancer Inst 55:425-432.
45. Unutmaz D, KewalRamani VN, Marmon S, Littman DR. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189:1735-1746. http://dx.doi.org/10.1084/jem.189.11.1735.
46. Nabel G, Baltimore D. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711-713. http://dx.doi.org/10.1038/326711a0.
47. Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. 1995. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol Med 1:667-677.
48. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E, White MR, Dinarello CA, Apte RN. 2011. IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187:4835-4843. http://dx.doi.org/10.4049/jimmunol.1102048.
49. van der Velden VH, Verheggen MM, Bernasconi S, Sozzani S, Naber BA, van der Linden-van Beurden CA, Hoogsteden HC, Mantovani A, Versnel M. 1998. Interleukin-1beta and interferon-gamma differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells. Eur Cytokine Netw 9:269-277.
50. Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. 2006. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol 176:284-290. http://dx.doi.org/10.4049/jimmunol.176.1.284.
51. Haile LA, Greten TF, Korangy F. 2012. Immune suppression: the hallmark of myeloid derived suppressor cells. Immunol Invest 41:581-594. http://dx.doi.org/10.3109/08820139.2012.680635.
52. Miao EA, Rajan JV, Aderem A. 2011. Caspase-1-induced pyroptotic cell death. Immunol Rev 243:206-214. http://dx.doi.org/10.1111/j.1600-065X.2011.01044.x.
53. Ahir S, Chaudhari D, Chavan V, Samant-Mavani P, Nanavati R, Mehta P, Mania-Pramanik J. 2013. Polymorphisms in IL-1 gene cluster and its association with the risk of perinatalHIVtransmission, in an Indian cohort. Immunol Lett 153:1-8. http://dx.doi.org/10.1016/j.imlet.2013.05.008.
54. Pontillo A, Oshiro TM, Girardelli M, Kamada AJ, Crovella S, Duarte AJS. 2012. Polymorphisms in inflammasome genes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 59:121-125. http://dx.doi.org/10.1097/QAI.0b013e3182392ebe.
55. Takebe N, Paredes J, Pino MC, Lownsbury WH, Agosti J, Krown SE. 1998. Phase I/II trial of the type I soluble recombinant human interleukin-1 receptor in HIV-1-infected patients. J Interferon Cytokine Res 18: 321-326. http://dx.doi.org/10.1089/jir.1998.18.321.